Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04419480 · ClinicalTrials.gov registry record · NA

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

A NA study of Heart Failure and Cardiogenic Shock, sponsored by Inova Health Care Services.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04419480 is a NA study of Heart Failure and Cardiogenic Shock that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 40 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04419480, a NA study of Heart Failure and Cardiogenic Shock, is actively recruiting participants, sponsored by Inova Health Care Services.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock

Interventions

  • DEVICE CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization

Study Locations (1)

Virginia

  • Inova Fairfax Medical Campus - Falls Church

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-12-31
Est. Completion 2028-12-31
Phase NA

Sponsor

Inova Health Care Services

75 total trials

What the Registry Record Tells You About NCT04419480

The ClinicalTrials.gov registry entry for NCT04419480 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization is the first listed.

NCT04419480 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04419480 about?

NCT04419480 is a clinical study titled "Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial". Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock

What is the current status of trial NCT04419480?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-12-31. Estimated completion is 2028-12-31.

What conditions does trial NCT04419480 study?

This clinical trial studies the following conditions: Heart Failure, Cardiogenic Shock, Ambulatory Hemodynamic Monitoring.

What interventions are being tested in trial NCT04419480?

The interventions under investigation include: CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization (DEVICE).

Who is sponsoring clinical trial NCT04419480?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04419480 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.